Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Maryville NURS 663 Exam 2 (Summer 2022 From Dr. Langford's test review) Questions with Cer, Exams of Nursing

Maryville NURS 663 Exam 2 (Summer 2022 From Dr. Langford's test review) Questions with Certified Solutions 2024-2025

Typology: Exams

2023/2024

Available from 06/23/2024

Bestnurse0
Bestnurse0 🇺🇸

3

(6)

1.5K documents

1 / 17

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Maryville NURS 663 Exam 2 (Summer
2022 From Dr. Langford's test review)
Questions with Certified Solutions 2024-
2025
Phases of Grief
· Shock and denial (days-weeks) acute anguish, lost patterns of conduct, resolution
(months-year)
· Denial, bargaining, depression, anger, acceptance
· No real timeline, comes in waves
Grief vs. MDD
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff

Partial preview of the text

Download Maryville NURS 663 Exam 2 (Summer 2022 From Dr. Langford's test review) Questions with Cer and more Exams Nursing in PDF only on Docsity!

Maryville NURS 663 Exam 2 (Summer

2022 From Dr. Langford's test review)

Questions with Certified Solutions 2024-

Phases of Grief · Shock and denial (days-weeks) acute anguish, lost patterns of conduct, resolution (months-year) · Denial, bargaining, depression, anger, acceptance · No real timeline, comes in waves Grief vs. MDD

· Grief - Sx may meet syndromal criteria for MDD episode, but survivor rarely has morbid feelings of guilt, worthlessness, SI, or psychomotor retardation o Considers self bereaved o Dysphoria often triggered by thoughts or reminders of the deceased o Onset within 2 months of bereavement o Duration of depressive episode is less than 2 months o Functional impairment is transient and mild o No family or personal hx of depression o Predominant affect is emptiness and loss o Pain of grief accompanied with positive emotions and humor, self-esteem generally preserved Previous Play Next Rewind 10 seconds Move forward 10 seconds Unmute 0: / 0: Full screen Brainpower Read More MDD vs. Grief MDD

Delirium Vs. Dementia Delirium o 4A & 3C: disturbance in a ttention and a wareness. o A brupt/acute onset with a ltering severity throughout the day. o C ognitive disturbance, c onsequence of another medical condition or substance related. o C an’t be explained by neuro-cognitive dx or coma o More short-term memory than long term memory impaired o Orientation grossly disorganized o Prominent hallucinations o Poor attention o Judgment, social skills, and behavior are grossly impaired o Associated with acute illness, vital signs often abnormal, neuro exam may be abnormal Dementia vs. Delirium Dementia o More long-term memory impaired than short term o Attention less impaired o Orientation varies o Rare hallucinations o Judgment, social kills, and behavior are initially relatively intact o Onset usually insidious o Short term course varies, but stable o Chronic and progressive Normal signs of aging and memory performance

o Everything tends to slow down as we age o Erikson: integrity vs despair. Central conflict is coping, maintaining self-esteem, reconciliation. o Complains about memory loss, but can provide detailed examples of forgetfulness o Occasionally searches for words o May have to pause for directions, but doesn't get lost in familiar places o Remembers recent important events, conversations not impaired o Interpersonal social skills not impaired Screening tools for neurocognitive disorders in the geriatric population Mini-mental status exam (MMSE)

  • Most widely used, cutoff > SLUMS exam -Effective at screening for executive function domain -HS education: score 27-30 normal. Scores 21-26 mild neurocognitive disorder, scores between 0-20 indicate dementia Mini-Cog -3 minute screening for cognitive impairment -Cut-off <3 for dementia screening Alzheimer's Disease o Cause: Abnormal deposits of proteins form amyloid plaques and tau tangles throughout the brain. o Short-term memory loss o Impaired executive function o Difficulty with ADLs

o REM sleep disturbances, insomnia, increased daytime sleepiness o Onset: 50+ Frontal Lobe Dementia o Cause: Abnormal amounts of Tau and TDP-43 accumulate in in the neurons of the frontal and temporal lobes o Progressive behavioral or personality changes that impair social conduct o Impulsive behaviors, emotional extremes (flatness or excessive) o Language impairment- difficulty making or understanding speech o Possible preserved episodic memory o Shaky hands, problems with balance and walking o Onset: between 45 & 64 Donezepil (Aricept) o Cholinesterase inhibitor o GI side effects: nausea/vomiting, diarrhea, (resolve within 3 weeks of use) o Bradycardia found usually in those with underlying heart disease o CYP-450 metabolism o Indicated for mild to severe cognitive impairment o Slows the progression of memory loss o Diminishes apathy, depression, hallucinations, anxiety, euphoria, purposeless motor behaviors o Helps retain cognitive and adaptive faculties at a stable level for several months o May be beneficial for Lewy body dementia and vascular dementia o Warning: may cause catastrophic reaction with signs of grief and agitation- DC use. Galantamine

o Cholinesterase inhibitor o GI side effects: dizziness, headache, nausea/vomiting, diarrhea, and anorexia (mild and transient) o CYP450 metabolism o Indicated for mild to moderate memory impairment o Rarely prescribed Memantine (Namenda) o NMDA receptor antagonist o May protect cells from excess glutamate by partially blocking NMDA receptors o Indicated for moderate to severe memory impairment o Fewer side effects than cholinergics, titrate over 4 weeks to target dose o Safe and well tolerated o Side effects: dizziness, headache, constipation, and confusion Do not use in severe renal impairment The risks of prescribing antipsychotics for patients with dementia · Black Box warning for all anti-psychotics · Increased risk of mortality of elderly patients with dementia-related psychosis · Primarily due to increased risk of cardiovascular events · Weigh risks vs benefits. · Know for education for families and patients Depression vs. Dementia · Depression o Onset can be dated with some precision o Rapid progression of sx after onset o Patients usually complain of some cognitive loss

o Most common in adolescent boys o Type of hypersomnolence o At least two episodes of excessive sleepiness and sleep duration, each persisting from two days to 5 weeks o Episodes occur multiple times a year, but at least once every 18 months o Patient has normal alertness, cognitive function, behavior, and mood in between episodes. o At least one of the following during an episode: cognitive dysfunction, altered perception, eating disorder (Anorexia or hyperphagia), or disinhibited behavior (hypersexuality, impulsive behaviors) Medications to treat insomnia -Benzodiazepine hypnotics -Non-benzo hypnotics (Z-drugs) -Antidepressants -Hypocretin/Orexin antagonist -Melatonin receptor angonists -Antihistamine -Antipsychotics (not reviewed) -Anticonvulsants (not reviewed) Benzodiazepine Hypnotics for insomnia o Benzodiazepine hypnotics o Estazolam, flurazepam, quazepam, temazepam, triazolam o Enhance GABA and galanin o Do not consume with alcohol or opiates- very dangerous Non-benzo hypnotics (Z-drugs)

o Eszopiclone, zaleplon, zolpidem o Black box warning: unsafe sleep behaviors o Enhance GABA and galanin o Taking with high fat meal will impact absorption and effect Antidepressants for insomnia o Trazadone -Mainly through antihistamine effects. -Dosing for sleep is lower: 25-150mg Doxepin Hypocretin/Orexin antagonist o Block orexin, decreases arousal and helps sleep o Suvorexant, Lemborexant Melatonin receptor angonists o Melatonin -acts on M1, M2, and M3. Helps with phase delayed sleep problems. Non- addictive, OTC. Not regulated o ramelteon, tasimelteon

  • Acts on M1 and M o Good for falling asleep, not for staying asleep o No risk of complex sleep behaviors, no addiction issues, doesn't suppress respiratory drive Antihistamine for insomnia o Diphenhydramine -Blocks histamine receptor, makes less arousal

o Binge/purge type- self-induced vomiting, laxative abuse, diuretic abuse, enema abuse. NOT BULIMIA- difference is extremely low body weight. o Severity based on BMI. o Extremely high mortality rate- 6x more likely to die. Mainly due to physiological complications, but 20% die by suicide o Physiological findings: lanugo, carotenemia (orange discoloration of skin, palms, does NOT affect sclera) Binge Eating Disorder o ED o BO- “binge eaters overeat”

  • Recurrent B inge episodes (1x week for 3 months)
  • O ut of control overeating o Plus 3+ more of the following:
  • Fast past full- eat faster than usual, uncomfortably full -Feast when not famished, tend to eat when not hungry
  • Flushed and flustered and feeling disgusted, can feel embarrassed or disgusted of behavior o Severity based on episodes per week -Mild- 1-3x week
  • Moderate- 4-7x week
  • Severe- 8-13x week
  • Extreme- 14x week o No regular compensatory behaviors, behavioral indicators for over eating are required for diagnosis, marked distress about binge eating. o Over concern about body weight/shape not required for dx, but often present

Bulimia Nervosa o ED o BOCP

  • Recurrent B inge episodes (1x week for 3months)
  • O ut of control overeating
  • Excessive C oncern with body weight/shape
  • P urging or other compensatory behaviors o Severity based on episodes per week
  • Mild- 1-3x week
  • Moderate- 4-7x week
  • Severe- 8-13x week
  • Extreme- 14x week o Physiological findings: Russell’s sign (callousing, scarring of dorsal side of hand from gagging self with hand to induce vomiting), hypertrophy of salivation glands (chipmunk cheeks) · Avoidant/restrictive food intake disorder o FD o Hallmark: avoiding or restricting what they're eating. -Can be result of bad experience with certain food. An eating or feeding disturbance (e.g., apparent lack of interest in eating or food; avoidance based on the sensory characteristics of food; concern about aversive consequences of eating) persistent failure to meet appropriate nutritional and/or energy needs associated with one (or more) of the following: -Significant weight loss (or failure to achieve expected weight gain or faltering growth in children).

of lead. Anemia can be cause o Differential Dxs: Autism and anemia Pica Treatment Treatments: physical and test for mineral imbalances, lead poisoning, etc. Control for behavior and environmental factors. CBT, daily logs to examine if there's a trigger or association of eating nonfood items. Seek to reduce impulse to eat abnormally Rumination Disorder o FD o Repeated regurgitation of food (to be rechewed, reswallowed, or spit out) for at least one month o Regurgitation is not due to medical condition o Regurgitation dues not occur solely during course of other feeding/eating disorder o If it occurs with another mental or medical condition, the severity o the eating behavior can warrant additional clinical attention o High rate of spontaneous remission o No FDA approved treatment. More of behavioral training Anorexia Nervosa Treatment o No FDA approved medications specifically for Anorexia. o May require medical treatment, hospitalization for dehydration/ electrolyte abnormalities o Treat other psychiatric issues such as anxiety, depression. o Psychotherapy (Usually CBT) Binge Eating Disorder Treatment

o Vyvanse (Lisdexamfetamine) o Psychotherapy (Usually CBT) Bulimia Nervosa Treatment o Fluoxetine (SSRI) o Psychotherapy (Usually CBT) Wellbutrin in Eating Disorders · Contraindicated in ANY eating disorder- Black box warning. Can increase risk of seizures.